Neuland Laboratories Ltd (NEULANDLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 229993, "name": "Neuland Labs.", "stock_name": "Neuland Labs.", "full_name": "Neuland Laboratories Ltd", "name_url": "stocks-analysis/neuland-labs", "exchange": 0, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "13,142.00", "chg": -435.65, "chgp": "-3.21%", "dir": -1, "prev_price": "13,577.65", "mcapval": "16,916.00 Cr", "mcap": "Small Cap", "scripcode": 524558, "symbol": "NEULANDLAB", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE794A01010", "curr_date": "Feb 02", "curr_time": "", "bse_nse_vol": "35.53 k", "exc_status": "Active", "traded_date": "Feb 02, 2026", "traded_date_str": "2026 02 02", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/neuland-labs-229993-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Neuland Laboratories Upgraded to Hold as Technicals Improve and Financials Strengthen", "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-upgraded-to-hold-as-technicals-improve-and-financials-strengthen-3815677", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NeulandLaborato_mojoScore_3815677.png", "date": "2026-02-02 08:10:46", "description": "Neuland Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical outlook and recent financial results. The upgrade, effective from 1 February 2026, is underpinned by a stabilising technical trend, robust quarterly earnings growth, and a solid institutional investor base, despite lingering concerns over valuation and long-term sales growth." }, { "title": "Why is Neuland Laboratories Ltd falling/rising?", "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-neuland-laboratories-ltd-fallingrising-3815103", "imagepath": "", "date": "2026-02-02 00:47:42", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Neuland Laboratories has outperformed its sector and the broader market in the short term. Over the past week, the stock gained 2.52%, contrasting with the Sensex's 1.00% decline during the same period. This positive momentum is further underscored by the stock’s consecutive gains over the last two days, delivering an 8.17% return in that timeframe. On 01-Feb, the stock reached an intraday high of ₹14,009.05, marking a 5.79% increase from previous levels. Such intraday strength indicates strong buying interest and optimism among investors.</p>\n<p>Despite this recent surge, the stock’s longer-term performance reveals some headwinds. Over the past month and year-to-date, Neuland Laboratories has declined by 9.22% and 10.62% respectively,..." }, { "title": "Neuland Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-technical-momentum-shifts-amid-mixed-market-signals-3813528", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NeulandLaborato_technicaldot_3813528.png", "date": "2026-02-01 08:00:44", "description": "Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of technical indicators. Despite a 5.16% rise in the stock price to ₹13,200 on 1 Feb 2026, the overall technical signals remain mixed, prompting a downgrade in its Mojo Grade from Hold to Sell as of 27 Jan 2026." }, { "title": "Neuland Laboratories Downgraded to Sell Amid Valuation and Growth Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-downgraded-to-sell-amid-valuation-and-growth-concerns-3806771", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NeulandLaborato_mojoScore_3806771.png", "date": "2026-01-28 08:05:36", "description": "Neuland Laboratories Ltd has been downgraded from a Hold to a Sell rating by MarketsMOJO as of 27 Jan 2026, reflecting concerns over its valuation, financial trends, and long-term growth prospects despite recent quarterly improvements. The pharmaceutical company’s current Mojo Score stands at 48.0, signalling caution for investors amid underperformance relative to the broader market." }, { "title": "Neuland Laboratories Declines 5.86%: Mixed Signals Amid Technical Shift and Financial Recovery", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-declines-586-mixed-signals-amid-technical-shift-and-financial-recovery-3804229", "imagepath": "", "date": "2026-01-25 13:00:11", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Jan 19:</strong> Technical momentum shifts amid mixed market signals</p>\n <p><strong>Jan 20:</strong> Investment rating upgraded to Hold following quarterly improvements</p>\n <p><strong>Jan 21-23:</strong> Stock price declines despite technical stabilisation</p>\n <p><strong>Jan 23:</strong> Week closes at ₹13,244.40 (-5.86%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹14,069.55</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">₹..." }, { "title": "Neuland Laboratories Ltd Upgraded to Hold Amid Mixed Financial and Technical Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-ltd-upgraded-to-hold-amid-mixed-financial-and-technical-signals-3795414", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NeulandLaborato_mojoScore_3795414.png", "date": "2026-01-20 08:07:52", "description": "Neuland Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and recent financial results. The upgrade, effective from 19 Jan 2026, is driven by a combination of stabilising technical trends, positive quarterly earnings, and a more favourable valuation outlook amid a challenging market backdrop." }, { "title": "Neuland Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-technical-momentum-shifts-amid-mixed-market-signals-3793630", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NeulandLaborato_technicaldot_3793630.png", "date": "2026-01-19 08:00:32", "description": "Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, with recent indicators signalling a transition from a mildly bearish trend to a more sideways movement. Despite a day-on-day decline of 1.46%, the stock’s technical landscape reveals a complex interplay of bullish and bearish signals, reflecting cautious investor sentiment amid broader market pressures." }, { "title": "Neuland Laboratories Downgraded to Sell Amid Mixed Financials and Bearish Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-downgraded-to-sell-amid-mixed-financials-and-bearish-technicals-3791440", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NeulandLaborato_mojoScore_3791440.png", "date": "2026-01-14 08:04:25", "description": "Neuland Laboratories Ltd has seen its investment rating downgraded from Hold to Sell as of 13 Jan 2026, reflecting a combination of deteriorating technical indicators, expensive valuation metrics, and concerns over long-term growth prospects despite recent positive quarterly financial results." }, { "title": "Neuland Laboratories Ltd Faces Mildly Bearish Technical Shift Amid Price Momentum Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-faces-mildly-bearish-technical-shift-amid-price-momentum-decline-3791250", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NeulandLaborato_technicaldot_3791250.png", "date": "2026-01-14 08:00:34", "description": "Neuland Laboratories Ltd has experienced a notable shift in its technical parameters, moving from a mildly bullish to a mildly bearish trend. This change is underscored by mixed signals from key indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a complex momentum landscape for the pharmaceutical and biotechnology firm as it navigates current market conditions." } ], "total": 723, "sid": "229993", "stock_news_url": "https://www.marketsmojo.com/news/neuland-laboratories-229993" }, "announcements": [ { "caption": "Intimation Regarding Conversion Of Statutory AuditorS Firm To A Limited Liability Partnership (LLP)", "datetime": "30-Jan-2026", "details": "Intimation regarding conversion of Statutory Auditors Firm to a LLP", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "27-Jan-2026", "details": "Q3FY26 Earnings Call Intimation", "source": "BSE" }, { "caption": "Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025", "datetime": "21-Jan-2026", "details": "Neuland Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "09 Feb 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Neuland Laboratories Ltd has declared <strong>120%</strong> dividend, ex-date: 18 Jul 25", "dt": "2025-07-18", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Neuland Laboratories Ltd has announced <strong>4:25</strong> rights issue, ex-date: 13 Aug 14", "dt": "2014-08-13", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

Jan 19: Technical momentum shifts amid mixed market signals

Jan 20: Investment rating upgraded to Hold following quarterly improvements

Jan 21-23: Stock price declines despite technical stabilisation

Jan 23: Week closes at ₹13,244.40 (-5.86%)

Read full news article

Neuland Laboratories Ltd Upgraded to Hold Amid Mixed Financial and Technical Signals

2026-01-20 08:07:52

Neuland Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and recent financial results. The upgrade, effective from 19 Jan 2026, is driven by a combination of stabilising technical trends, positive quarterly earnings, and a more favourable valuation outlook amid a challenging market backdrop.

Read full news article

Neuland Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-01-19 08:00:32

Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, with recent indicators signalling a transition from a mildly bearish trend to a more sideways movement. Despite a day-on-day decline of 1.46%, the stock’s technical landscape reveals a complex interplay of bullish and bearish signals, reflecting cautious investor sentiment amid broader market pressures.

Read full news article

Neuland Laboratories Downgraded to Sell Amid Mixed Financials and Bearish Technicals

2026-01-14 08:04:25

Neuland Laboratories Ltd has seen its investment rating downgraded from Hold to Sell as of 13 Jan 2026, reflecting a combination of deteriorating technical indicators, expensive valuation metrics, and concerns over long-term growth prospects despite recent positive quarterly financial results.

Read full news article

Neuland Laboratories Ltd Faces Mildly Bearish Technical Shift Amid Price Momentum Decline

2026-01-14 08:00:34

Neuland Laboratories Ltd has experienced a notable shift in its technical parameters, moving from a mildly bullish to a mildly bearish trend. This change is underscored by mixed signals from key indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a complex momentum landscape for the pharmaceutical and biotechnology firm as it navigates current market conditions.

Read full news article